Portfolio company
Rani
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Rani Therapeutics develops oral capsules that deliver biologic medicines directly into the intestinal wall for patients with chronic conditions requiring regular injections.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Biograil
This biotech company develops a capsule device that enables oral delivery of injectable biologic drugs for pharmaceutical firms and patients.
Drug Delivery
This company develops ingestible technology for drug delivery and health monitoring to serve patients and healthcare providers.
Exolvo Biosciences
Exolvo Biosciences develops oral smart capsules for the delivery of biologic drugs to pharmaceutical companies and patients.
Exolvo
This company develops smart capsules using dissolvable microneedles for the oral delivery of biologic drugs to pharmaceutical partners and patients.
I2 Therapeutics
This company develops oral drug delivery formulations and long-acting therapies for metabolic and inflammatory diseases to improve patient adherence and treatment efficacy.
Nexos
Nexos Biosciences develops exosome-based drug delivery systems for pharmaceutical companies to enable oral administration of treatments for cancer, inflammation, and metabolic diseases.
Intarcia Therapeutics
This biopharmaceutical company develops subcutaneous drug delivery implants for patients with chronic diseases such as type 2 diabetes and HIV.
EnteroBiotix
This biopharmaceutical company develops orally administered microbial therapeutics for patients with gastrointestinal diseases, including irritable bowel syndrome and blood cancers.
